your market intelligence analyst
Search Results
27 results
Your search is now limited to «Leukemia» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
Healio News 07/21/2019 08:00
CHICAGO — Bijal D. Shah, MD, associate professor in the department of malignant hematology at Moffitt Cancer Center, spoke with HemOnc Today at ASCO Annual Meeting about the ZUMA-3 study. The phase 1/phase 2 study evaluated KTE-X19 (Kite Pharma), an investigational anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for adults with relapsed/refractory acute lymphoblastic leukemia. Shah provided an overview of end-of-phase-1 results. “We were able to identify a cell dose and a toxicity management algorithm that seems to come with highly encouraging response rates and highly.
Healio News 06/01/2019 14:33
CHICAGO — Patients who received high-intensity bridging chemotherapy before CD19 chimeric androgen receptor T-cell therapy for relapsed or refractory acute lymphoblastic leukemia demonstrated significantly higher risk for infection than patients who received low-intensity or no bridging therapy, according to data presented at ASCO Annual Meeting.
Healio News 05/29/2019 17:25
DESTIN, Fla. — The classical findings of the rare condition Felty’s syndrome, which include rheumatoid arthritis, splenomegaly and neutropenia, can make differentiating between Felty’s and T-cell large granular lymphocyte leukemia very difficult, according to Jonathan A. Aun, DO, of the Keesler Medical Center, at Keesler Air Force Base in Biloxi, Mississippi.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications